EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways

Kate R Oppegaard, Yvette P Conley, Steven Paul, Bruce Cooper, Carolyn S Harris, Joosun Shin, Lisa Morse, Jon D Levine, Frances Cartwright, Ritu Roy, Michelle Melisko, Kord M Kober und 2 weitere

Journal of Neural Transmission · 2025

DOI: 10.1007/s00702-024-02824-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neural Transmission, 2025. Verfasst von Kate R Oppegaard und 13 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber Cancer Institute, University of Massachusetts, Boston, MA, USA. Hauptthemen laut MEDLINE: Synaptic Transmission, Neoplasms, Cognitive Dysfunction, Chemotherapy-Related Cognitive Impairment. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer-related cognitive impairment (CRCI) is reported by 45% of patients with cancer. Significant gaps in knowledge remain regarding the mechanisms that underlie CRCI.

Objectives

Using a data-driven approach, the study purpose was to evaluate for perturbed pathways associated with membership in the High versus the Low CRCI profiles.

Methods

Patients completed the Attentional Function Index six times over two cycles of chemotherapy. Using findings from a previous latent profile analysis, subgroups of patients with high versus low levels of CRCI were evaluated (i.e., High versus Low CRCI profiles). Gene expression was quantified using either ribonucleic (RNA)-sequencing or microarray analyses and pathway impact analyses were performed. Signaling pathways were defined using the Kyoto Encyclopedia of Genes and Genomes database.

Results

A total of 508 patients had data available for analysis. Of the 261 patients in the RNA-sequencing sample, 48.7% were in the High class and 51.3% were in the Low class. Of the 247 patients the microarray sample, 46.6% were in the High class and 53.4% were in the Low class. Pathway impact analyses identified seven perturbed pathways related to neurotransmission (i.e., glutamatergic synapse, GABAergic synapse, dopaminergic synapse, serotonergic synapse, long-term depression, cholinergic synapse, retrograde endocannabinoid signaling).

Conclusions

This study is the first to describe associations between self-reported CRCI in patients receiving chemotherapy for breast, gastrointestinal, gynecological, or lung cancer and seven neurotransmission pathways. These findings provide new insights into potential targets for mechanistically based interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Synaptic TransmissionNeoplasmsCognitive DysfunctionChemotherapy-Related Cognitive ImpairmentHumansFemaleMaleMiddle AgedAgedSelf ReportSignal TransductionAdult

Stichwörter der Autor:innen

CancerChemotherapy-related cognitive impairmentCognitionGene expressionNeurotransmissionPathway analysisPatient-reported outcomes

Autor:innen und Institutionen

  • Dana-Farber Cancer Institute, University of Massachusetts, Boston, MA, USA.
  • School of Nursing, University of Pittsburg, Pittsburgh, PA, USA.
  • School of Nursing, University of California, 2 Koret Way - N631Y, San Francisco, CA, 94143-0610, USA.
  • The Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA, USA.
  • School of Medicine, University of California, San Francisco, CA, USA.
  • Mount Sinai Health System, New York, NY, USA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Oppegaard, K. R., Conley, Y. P., Paul, S., Cooper, B., Harris, C. S., Shin, J., Morse, L., Levine, J. D., Cartwright, F., Roy, R., Melisko, M., Kober, K. M., Hammer, M. J., & Miaskowski, C. (2025). Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways. Journal of Neural Transmission. https://doi.org/10.1007/s00702-024-02824-9

Vancouver

Oppegaard KR, Conley YP, Paul S, Cooper B, Harris CS, Shin J, et al. Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways. Journal of Neural Transmission. 2025. doi:10.1007/s00702-024-02824-9

BibTeX
@article{Oppegaard2025,
  author = {Oppegaard, Kate R and Conley, Yvette P and Paul, Steven and Cooper, Bruce and Harris, Carolyn S and Shin, Joosun and Morse, Lisa and Levine, Jon D and Cartwright, Frances and Roy, Ritu and Melisko, Michelle and Kober, Kord M and Hammer, Marilyn J and Miaskowski, Christine},
  title = {Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways},
  journal = {Journal of Neural Transmission},
  year = {2025},
  doi = {10.1007/s00702-024-02824-9}
}
Kostenlos starten →